Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection has had a serious worldwide impact on human health. On December 2020, an immunization campaign with a COVID‐19 mRNA vaccine (Comirnaty‐BNT162b2 Pfizer‐BioNTech)… Click to show full abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection has had a serious worldwide impact on human health. On December 2020, an immunization campaign with a COVID‐19 mRNA vaccine (Comirnaty‐BNT162b2 Pfizer‐BioNTech) was started in Italy, first targeting healthcare workers (HCWs). This study aims to investigate the antibodies that are response against SARS‐CoV‐2 vaccine.
               
Click one of the above tabs to view related content.